Inventor · disambiguated record
Xialing Guo
Also filed as: GUO XIALING
21 granted patents·4 pending applications·189 citations·filing 2002–2017
94Inventor score
Top patents by PatentIndex Score
25 records- 0196US6747025B1Kinase inhibitors for the treatment of diseaseALLERGAN INC·Filed 2003·Granted Jun 8, 2004·57 cites·9 claims
- 0293US6541504B1(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN SALES LLC·Filed 2002·Granted Apr 1, 2003·61 cites·18 claims
- 0388US7060844B2(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2003·Granted Jun 13, 2006·29 cites·3 claims
- 0487US8614234B2Compounds as tyrosine kinase modulatorsGUO XIALING·Filed 2010·Granted Dec 24, 2013·10 cites·26 claims
- 0584US8906944B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2012·Granted Dec 9, 2014·8 cites·4 claims
- 0682US8367664B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Feb 5, 2013·3 cites·11 claims
- 0780US9328103B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2013·Granted May 3, 2016·3 cites·7 claims
- 0879US8809534B2Compounds as tyrosine kinase modulatorsGUO XIALING·Filed 2010·Granted Aug 19, 2014·3 cites·4 claims
- 0979US7977351B2Heteroaryl dihydroindolones as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Jul 12, 2011·3 cites·19 claims
- 1078US8877923B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Nov 4, 2014·2 cites·3 claims
- 1177US9340555B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2014·Granted May 17, 2016·1 cites·3 claims
- 1276US9725433B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2016·Granted Aug 8, 2017·1 cites·10 claims
- 1376US8455656B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Jun 4, 2013·2 cites·2 claims
- 1474US8865682B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Oct 21, 2014·1 cites·4 claims
- 1574US8455535B2Heteroaryl dihydroindolones as kinase inhibitorsBORAL SOUGATO·Filed 2011·Granted Jun 4, 2013·3 cites·21 claims
- 1674US8338415B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsGUO XIALING·Filed 2007·Granted Dec 25, 2012·1 cites·6 claims
- 1773US9475801B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2015·Granted Oct 25, 2016·1 cites·15 claims
- 1867US9657005B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Granted May 23, 2017·0 cites·1 claims
- 1966US9758509B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Sep 12, 2017·0 cites·1 claims
- 2066US2015099746A1Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 2163US10221192B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 2256US2016355527A1Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2016·Application pending·0 cites
- 2352US7531665B2Kinase inhibitors for the treatment of diseaseALLERGAN INC·Filed 2004·Granted May 12, 2009·0 cites·8 claims
- 2451US2013267497A1Kinase inhibitorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2539US2006004084A1(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsANDREWS STEVEN W·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xialing Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →